What is the equity of Ocumension Therapeutics this year?
Ocumension Therapeutics has equity of 2.92 B CNY this year.
Ocumension Therapeutics Equity 2024
Ocumension Therapeutics Equity
2.92 B CNY
Ticker
1477.HK
ISIN
KYG674111011
WKN
A2P723
In 2024, Ocumension Therapeutics's equity was 2.92 B CNY, a 6.23% increase from the 2.75 B CNY equity in the previous year.
Ocumension Therapeutics Aktienanalyse
What does Ocumension Therapeutics do?
Ocumension Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Ocumension Therapeutics's Equity
Ocumension Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ocumension Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Ocumension Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Ocumension Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Ocumension Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Ocumension Therapeutics stock
What was the equity of Ocumension Therapeutics compared to the previous year?
The equity of Ocumension Therapeutics has increased/decreased by 6.23% increased compared to the previous year.
What impact does a high equity have on investors of Ocumension Therapeutics?
A high equity is advantageous for investors of Ocumension Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Ocumension Therapeutics?
A low equity can be a risk for investors of Ocumension Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Ocumension Therapeutics affect the company?
An increase in equity of Ocumension Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Ocumension Therapeutics affect the company?
A reduction in equity of Ocumension Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Ocumension Therapeutics?
Some factors that can affect the equity of Ocumension Therapeutics include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Ocumension Therapeutics so important for investors?
The equity of Ocumension Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Ocumension Therapeutics take to change the equity?
To change equity, Ocumension Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Ocumension Therapeutics pay?
Over the past 12 months, Ocumension Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ocumension Therapeutics is expected to pay a dividend of 0 CNY.
What is the dividend yield of Ocumension Therapeutics?
The current dividend yield of Ocumension Therapeutics is .
When does Ocumension Therapeutics pay dividends?
Ocumension Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ocumension Therapeutics?
Ocumension Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Ocumension Therapeutics?
For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ocumension Therapeutics located?
Ocumension Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ocumension Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ocumension Therapeutics from 9/13/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Ocumension Therapeutics pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Ocumension Therapeutics in the year 2023?
In the year 2023, Ocumension Therapeutics distributed 0 CNY as dividends.
In which currency does Ocumension Therapeutics pay out the dividend?
The dividends of Ocumension Therapeutics are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ocumension Therapeutics
Our stock analysis for Ocumension Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ocumension Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Ocumension Therapeutics Revenue
- Ocumension Therapeutics Net Income
- Ocumension Therapeutics P/E
- Ocumension Therapeutics P/S
- Ocumension Therapeutics EBIT
- Ocumension Therapeutics Dividend
- Ocumension Therapeutics Stocks
- Ocumension Therapeutics Market capitalization
- Ocumension Therapeutics Debt
- Ocumension Therapeutics Liabilities
- Ocumension Therapeutics Equity
- Ocumension Therapeutics AAQS
- Ocumension Therapeutics Employees
- Ocumension Therapeutics ROE
- Ocumension Therapeutics ROA
- Ocumension Therapeutics ROCE